Rapid resensitization of purinergic receptor function in human platelets

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 8, 2008, Pages 1393-1404

  Mundell, S J ^a   Barton, J F ^a   Mayo Martin, M B ^a   Hardy, A R ^a   Poole, Alastair W ^a  

^a SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

Author keywords

Endocytosis; Human platelet; P2Y; Phosphatase; Recycling; Resensitization

Indexed keywords

ADENOSINE DIPHOSPHATE; DYNAMIN; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y2 RECEPTOR;

ARTICLE; ASTROCYTOMA CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; RECEPTOR DOWN REGULATION; RECEPTOR RESENSITIZATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THROMBOCYTE;

ADENOSINE DIPHOSPHATE; BLOOD PLATELETS; CALCIUM; CELL LINE; CYCLIC AMP; HUMANS; MONENSIN; PLATELET ACTIVATION; RECEPTORS, PURINERGIC; RECEPTORS, PURINERGIC P2; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 47749134904     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.03039.x     Document Type: Article

References (38)

1. Kunapuli SP, Ding Z, Dorsam RT, Kim S, Murugappan S, Quinton TM. ADP receptors-targets for developing antithrombotic agents. Curr Pharm Des 2003; 9: 2303-16.
2. Gachet C. Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 2005; 21: 277-300.
3. Hanyaloglu AC, von Zastrow M. Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol 2008; 48: 537-68.
4. Hardy AR, Conley PB, Luo J, Benovic JL, Poole AW, Mundell SJ. P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. Blood 2005; 105: 3552-60.
5. Poole AW, Heath MF, Evans RJ. ADP induces desensitisation of equine platelet aggregation responses: Studies using ADP beta S, a stable analogue of ADP. Res Vet Sci 1993; 54: 235-43.
6. Baurand A, Eckly A, Hechler B, Kauffenstein G, Galzi JL, Cazenave JP, Leon C, Gachet C. Differential regulation and relocalization of the platelet P2Y receptors after activation: A way to avoid loss of hemostatic properties? Mol Pharmacol 2005; 67: 721-33.
7. Cauwenberghs S, Feijge MA, Hageman G, Hoylaerts M, Akkerman JW, Curvers J, Heemskerk JW. Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: Importance for platelet activity during thrombus formation. Transfusion 2006; 46: 1018-28.
8. Ferguson SSG. Evolving concepts in G protein-coupled receptor endocytosis: The role in receptor desensitisation and signalling. Pharmacol Rev 2001; 53: 1-24.
9. von Zastrow M. Mechanisms regulating membrane trafficking of G protein-coupled receptors in the endocytic pathway. Life Sci 2003; 74: 217-24.
10. Drake MT, Shenoy SK, Lefkowitz RJ. Trafficking of G protein-coupled receptors. Circ Res 2006; 99: 570-82.
11. Moore CA, Milano SK, Benovic JL. Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol 2007; 69: 451-82.
12. Gaborik Z, Hunyady L. Intracellular trafficking of hormone receptors. Trends Endocrinol Metab 2004; 15: 286-93.
13. Mundell SJ, Jones ML, Hardy AR, Barton JF, Beaucourt SM, Conley PB, Poole AW. Distinct roles for protein kinase C isoforms in regulating platelet purinergic receptor function. Mol Pharmacol 2006; 70: 1132-42.
14. Mundell SJ, Luo J, Benovic JL, Conley PB, Poole AW. Distinct clathrin-coated pits sort different G protein-coupled receptor cargo. Traffic 2006; 7: 1420-31.
15. Maxfield FR, McGraw TE. Endocytic recycling. Nat Rev Mol Cell Biol 2004; 5: 121-32.
16. Roevens P, de Chaffoy de Courcelles D. Desensitization and resensitization of human platelets to 5-hydroxytryptamine at the level of signal transduction. Biochem J 1995; 307: 775-82.
17. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 2006; 10: 839-50.
18. Poole AW, Watson SP, Heath MF, Evans RJ. Regulation of cytosolic calcium by collagen in single human platelets. Br J Pharmacol 1995; 115: 101-6.
19. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50.
20. Mundell SJ, Benovic JL, Kelly E. Selective inhibition of adenosine A2 receptor desensitization in NG108-15 cells stably transfected with dominant negative mutant GRK2. Mol Pharmacol 1997; 51: 991-8.
21. Daunt DA, Hurt C, Hein L, Kallio J, Feng F, Kobilka BK. Subtype-specific intracellular trafficking of alpha2-adrenergic receptors. Mol Pharmacol 1997; 51: 711-20.
22. Mundell SJ, Matharu AL, Kelly E, Benovic JL. Arrestin isoforms dictate differential kinetics of A2B adenosine receptor trafficking. Biochemistry 2000; 39: 12828-36.
23. Newton AJ, Kirchhausen T, Murthy VN. Inhibition of dynamin completely blocks compensatory synaptic vesicle endocytosis. Proc Natl Acad Sci U S A 2006; 103: 17955-60.
24. Krueger KM, Daaka Y, Pitcher JA, Lefkowitz RJ. The role of sequestration in G protein-coupled receptor resensitization. J Biol Chem 1997; 272: 5-8.
25. Pippig S, Andexinger S, Lohse MJ. Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization. Mol Pharmacol 1995; 47: 666-76.
26. Signoret N, Christophe T, Oppermann M, Marsh M. pH-independent endocytic cycling of the chemokine receptor CCR5. Traffic 2004; 5: 529-43.
27. Veyrat-Durebex C, Pomerleau L, Langlois D, Gaudreau P. Internalization and trafficking of the human and rat growth hormone-releasing hormone receptor. J Cell Physiol 2005; 203: 335-44.
28. Leterrier C, Bonnard D, Carrel D, Rossier J, Lenkei Z. Constitutive endocytic cycle of the CB1 cannabinoid receptor. J Biol Chem 2004; 279: 36013-21.
29. Schonthal AH. Role of PP2A in intracellular signal transduction pathways. Front Biosci 1998; 3: D1262-73.
30. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG. Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J Biol Chem 1999; 274: 32248-57.
31. Flores RV H-PM, Aquino E, Garrad RC, Weisman GA, Gonzalez FA. Agonist-induced phosphorylation and desensitization of the P2Y2 nucleotide receptor. Mol Cell Biochem 2005; 280: 34-45.
32. Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD, Esch JS II, Imai M, Edelberg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC, Rosenberg RD. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 1999; 5: 1010-7.
33. Tulapurkar ME, Zundorf G, Reiser G. Internalization and desensitization of a green fluorescent protein-tagged P2Y nucleotide receptor are differently controlled by inhibition of calmodulin-dependent protein kinase II. J Neurochem 2006; 96: 624-34.
34. Cao TT, Deacon HW, Reczek D, Bretscher A, von Zastrow M. A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor. Nature 1999; 401: 286-90.
35. Fam SR PM, Castleberry AM, Oller H, Lee CJ, Traynelis SF, Smith Y, Yun CC, Hall RA. P2Y1 receptor signaling is controlled by interaction with the PDZ scaffold NHERF-2. Proc Natl Acad Sci USA 2005; 102: 8042-7.
36. Hall RA, Ostedgaard LS, Premont RT, Blitzer JT, Rahman N, Welsh MJ, Lefkowitz RJ. A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. Proc Natl Acad Sci USA 1998; 95: 8496-501.
37. Cosemans JM, Munnix IC, Wetzker R, Heller R, Jackson SP, Heemskerk JW. Continuous signaling via PI3K isoforms beta and gamma is required for platelet ADP receptor function in dynamic thrombus stabilization. Blood 2006; 108: 3045-52.
38. Goto S, Tamura N, Ishida H, Ruggeri ZM. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5′-diphosphate receptor stimulation and cyclic calcium signaling. J Am Coll Cardiol 2006; 47: 155-62.